10-Q

Company

Aclaris Therapeutics, Inc.

Filed

November 6, 2023

Period of Report

September 30, 2023

Accession Number

0001558370-23-017660

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →